DiaMedica Therapeutics
DMAC
DMAC
11 hedge funds and large institutions have $4.6M invested in DiaMedica Therapeutics in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.14M | |
| 2 | +$47K | |
| 3 | +$14K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$6.65K |
| 5 |
CHP
Cable Hill Partners
Portland,
Oregon
|
+$5K |
Top Sellers
| 1 | -$640K | |
| 2 | -$220K | |
| 3 | -$45.4K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$17K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4K |